Whalesbook
Asal mein, India mein Dettol, Durex, aur Finish jaise brands ne kamaal kar diya. CEO Kris Licht ne bataya ki Harpic aur Lizol ke liye bhi distribution badhaya gaya hai, jis se sales mein bohot help mili. Ye India ki performance dekh ke lagta hai ki emerging markets, jismein India aur China shamil hain, wohi asli growth engine ban gaye hain. Inki wajah se group ka core business 3.1% grow kar paya.
Lekin bhai, global picture thoda alag hai. Europe mein toh revenue 4.2% gir gaya, mainly kam demand aur competition ki wajah se. North America mein bhi 0.9% ki kami aayi, haalanki Lysol jaise kuch products mein mid-single digit growth dikha. Is baar cold aur flu ka season bhi halka raha, jisne bhi impact dala.
Itni mixed news ke beech, company ke shares bhi 5.6% neeche gir gaye, ab lagbhag 4,644.00 pence par trade ho rahe hain.
Ek aur tension wali baat hai commodity prices, especially oil prices. Middle East ke conflicts ki wajah se oil prices badh sakte hain, jo Reckitt ke raw materials ko bhi affect karega. Unke 40% raw materials oil prices se linked hain. Isi wajah se pehle quarter mein bhi unhe similar issues face karne pade the.
Financials ki baat karein toh current ratio 0.85 hai aur debt-to-equity ratio 108.83%, jo thoda liquidity concern dikha raha hai. Stock bhi apne 52-week low ke paas chal raha hai. Par company ne apna full-year outlook maintain rakha hai, 4% se 5% tak ka core LFL net revenue growth expect kar rahe hain. Unka kehna hai ki Q2 se performance behtar hogi, kyunki cold and flu season normal hoga aur Europe mein execution sudhrega.
Analysts abhi bhi stock ko 'Hold' keh rahe hain, average target price GBX 6,219.86 hai. Company apna £1 billion ka share buyback bhi continue kar rahi hai, jisme se £669 million already ho chuka hai.